Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Leukemia, Myeloid, Acute 15Precursor Cell Lymphoblastic Leukemia-Lymphoma 11Myelodysplastic Syndromes 11Multiple Myeloma 11Lymphoma, Non-Hodgkin 11Hodgkin Disease 11Leukemia, Lymphocytic, Chronic, B-Cell 9Hematologic Neoplasms 9Myeloproliferative Disorders 8Leukemia, Myelomonocytic, Chronic 8Lymphoma, Mantle-Cell 7Leukemia 7Lymphoma, Follicular 6Lymphoma 6Lymphoma, B-Cell, Marginal Zone 5Leukemia, Myelogenous, Chronic, BCR-ABL Positive 5Leukemia, Biphenotypic, Acute 5Waldenstrom Macroglobulinemia 4Lymphoma, Large B-Cell, Diffuse 4Leukemia, Myeloid, Accelerated Phase 4Carcinoma, Renal Cell 4Burkitt Lymphoma 4Anemia, Refractory, with Excess of Blasts 4Anemia, Aplastic 4Lymphoma, T-Cell, Cutaneous 3Lymphoma, Large-Cell, Immunoblastic 3Leukemia, Myeloid, Chronic-Phase 3Congenital Abnormalities 3Blast Crisis 3Thrombocythemia, Essential 2

Interventions

fludarabine 1Whole-Body Irradiation 1Tacrolimus 1Stem Cell Transplantation 1Rituximab 1Mycophenolic Acid 1Melphalan 1Granulocyte Colony-Stimulating Factor 1Filgrastim 1Cyclophosphamide 1CT-P10 1Bendamustine Hydrochloride 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1/2 × Hematopoietic and Lymphoid System Neoplasm × Whole-Body Irradiation × Clear all
NCT04022239 2026-01-12

Bendamustine With or Without Cyclophosphamide in Preventing GVHD in Patients Undergoing Stem Cell Transplant

M.D. Anderson Cancer Center

Phase 1/2 Recruiting
25 enrolled

Hematopoietic and Lymphoid System Neoplasm

Data powered by HemOnc (CC BY 4.0) Colophon âš¡